Annotation Detail

Information
Associated Genes
LCN2
Associated Variants
LCN2 MUTATION
LCN2 MUTATION
Associated Disease
Malignant neoplasm of urinary bladder
Source Database
DisGeNET
Description
Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-κB and C/EBP-α significantly reduced LCN2 promoter activity.
Pubmed
24570342
Section of the abstract supporting the evidence
ALL_TEXT_2/3
Number of the section of the abstract supporting the evidence
2
Number of the sentence supporting the evidence
3
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.000271441872080303
Drugs